How Sequestration Will Affect the Health-Care Sector and Your Pocketbook: Gilead Sciences, Inc. (GILD), Life Technologies Corp. (LIFE)

Page 1 of 2

Stop me if you’ve heard this joke before: “Two political parties walk into a bar; both point the finger at each other for the country’s fiscal mess, yet neither is willing to budge an inch from their underlying views…” My guess is you’ve heard this one all too often and it’s not even funny anymore… because the truth rarely is.

Gilead Sciences, Inc. (NASDAQ:GILD)The highly anticipated sequestration, aimed at removing $1.1 trillion out of the federal budget over the next decade, kicked into effect on March 1, and is set to gradually, but decisively, remove $85 billion from the federal budget. These cuts are going to come from all walks of government – from USDA inspectors, to military spending, and even entitlement programs like Medicare, which is expected to see approximately a 2% reduction in reimbursements.

Today, I want to take a closer look at how sequestration could impact the health care sector.

As you might imagine, many of the effects of removing government funding tend to be negative — but it’s not as cut-and-dried as it might appear on the surface.

How it’ll affect safety
The most immediate impact of sequestration appears to be whether patient and consumer safety will be affected negatively. On the surface I’d say this is a distinct possibility with the Centers for Disease Control and Prevention seeing nearly a $450 million cut in its budget and the FDA, whose expenses are predominantly tied to its personnel costs, alluding that a $318 million reduction in funds will result in layoffs or furloughs totaling 2,100 USDA food inspectors.

Food safety looks like a clear loser with Tyson Foods, Inc. (NYSE:TSN) and Smithfield Foods, Inc. (NYSE:SFD) projected to suffer from USDA furloughs. By law, processed meat cannot be sold in stores without having been inspected, leaving Tyson and Smithfield in a big bind come the summer time when these furloughs are expected to hit the hardest. The end result may be less meat on supermarket shelves and higher prices because of it.

The bigger concern here actually stems from the CDC’s reduced budget. As GlobalData analysts noted this past week, one of the CDC’s primary functions is to provide educational and preventative materials and products to curb the spread of infectious diseases such as hepatitis and HIV. A lack of funding here could result in higher occurrences of these infectious diseases. However, I disagree with their analysis that this negative occurrence could have the hidden benefit of driving down costs as providers opt for cheaper drugs in the HIV space, hurting the launch of expensive new offerings like. Gilead Sciences, Inc. (NASDAQ:GILD)‘s four-in-one HIV medication, Stribild. Made with all in-house compounds, if Stribild supplants Gilead Sciences, Inc. (NASDAQ:GILD)’s current best-selling HIV treatment, Atripla, it will result in higher margins for the company. Keeping things in perspective, I wouldn’t expect a huge spike in HIV occurrences, but I wouldn’t be surprised if documented cases rose year-over-year.

How it’ll affect research and development
Research and development in pharmaceuticals, biotech, and life sciences looks like it’ll be a bit of a mixed bag. The National Institutes of Health is expected to be dealt a big blow with a reduction in funding of more than $1.6 billion. That means somewhere in the neighborhood of 2,000 fewer grants will be issued. In addition, a reduction in FDA budgets, while being dealt with largely on the food inspection front, could translate to slower drug and device approval. That would be bad news for potential drugs that aren’t set to be examined by the FDA until the latter half of 2013, including GlaxoSmithKline plc (ADR) (NYSE:GSK) and Theravance Inc (NASDAQ:THRX)‘s revolutionary long-term COPD treatment, Anoro, which I declared as a game-changing drug hopeful late last year.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top Businesses to Invest In

Top 5 Things You Might Be Doing Wrong With Your Business

Top 5 Strategic Technology Trends in 2014

Top Rags to Riches Stories

Parenting Behavior That Promotes Future Leaders

Top 5 Mistakes Made by Small Businesses

Top 5 Most Common and Potentially Devastating Financial Blunders

Top 5 Highest Paying Jobs for Web Designers

Top 6 Most Respected Professions that Also Pay Well

Top 5 Pitfalls Investors Should Avoid

Top 6 Lawyers and Policy Makers Under 30

Top 6 New Year’s Resolutions for Entrepreneurs

Top 7 Locations to Check in on Facebook

Top 5 Mistakes made by Rookie eBay Sellers

Top 7 eBook Publishers in 2013

Top 6 Health Industry Trends in 2014

5 Lessons for Entrepreneurs from Seth Godin

Top 5 Success Tips from Jordan Belfort – the Wolf of Wall Street

Best Master’s in Finance Degree Programs

Top 6 Earning Celebrities Over 50

The most expensive sports to play

Top 7 Earning Celebrities Under 25

Best 7 Online Courses to Take: Free Finance MOOCs

Top 6 Bad Habits that Promote Failure

20 Most Valuable Soccer Teams in the World in 2013

12 Most Expensive Countries for Foreign Students

Top 30 Most Influential Women in the World

Top 20 Most Expensive New Year Eve Shows

Top 5 Best Vocational Careers

Top 10 Jobs for 2014 by Salary Gain (Predictions)

Top 5 Digital Trends for 2014

Top 6 Things You Can Do To Increase Your Productivity

Top 9 Trending Smartphones in 2013

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!